Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Utibapril is an inhibitor of angiotensin-converting enzyme (ACE) with antihypertensive activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Utibapril is an inhibitor of angiotensin-converting enzyme (ACE) with antihypertensive activities. |
In vivo | Utibapril significantly inhibits plasma, renal, and vascular ACE but not ventricular ACE activity. vascular ACE activity significantly inhibited by Utibapril (2 μg/kg/day), and Utibapril (250 μg/kg/day) results in a significant inhibition of plasma ACE.After treatment with the higher doses of utibapril, Furthermore, angiotensin I-induced decreases in coronary flow in the isolated heart are significantly inhibited [1]. FPL 63547 is rapidly and extensively excreted as the diacid in the bile but appeared in the urine in negligible amounts[2]. |
Synonyms | FPL 63547 |
Molecular Weight | 449.56 |
Formula | C22H31N3O5S |
CAS No. | 109683-61-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Utibapril 109683-61-6 Others FPL63547 FPL-63547 FPL 63547 inhibitor inhibit